Monoclonal Antibodies

​

The FDA has approved emergency usage of monoclonal antibodies as a treatment for mild to moderate COVID-19 for patients at high risk of progressing to severe disease. They are currently available for 12 years of age and older in patients with certain high risk conditions. If your child is positive for COVID-19 and you think they may qualify, reach out to your primary care provider. A few details to be aware of:

​

                           *Treatment must be started within 10 days of onset (ideally the sooner the better)

                           *Treatment is a one time, outpatient, approximately 3 hour, IV infusion

                           *Currently not meant as a standard treatment, but for patients with high risk conditions as detailed in                                         articles below

​

AAP Article Review

FDA Fact Sheet for Patients, Parents and Caregivers

CDC Treatments

COVID-19 Vaccine

 

The arrival of the Moderna and Pfizer vaccines is one huge step towards achieving herd immunity and combating the COVID-19 pandemic. We will continue to keep the NWFP community informed of vaccine updates in the pediatric world.

​

Some current pertinent information:

​

Massachusetts vaccine program and roll out

CDC COVID-19 Vaccine

V-safe after vaccination health check (smart phone app)

ACOG Statement on vaccination in pregnant and lactating women

More Information re vaccination in pregnanct and lactating women

​

​